Kodiak Sciences Inc (KOD)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| CEO: | Victor Perlroth |
| Employees: | 90 |
| Web site: | kodiak.com |
|
1200 PAGE MILL RD, PALO ALTO, CA, 94304
650-281-0850
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Kodiak Sciences Inc. researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD) The company was formerly known as Oligasis, LLC.
Please log in first to see chart